In melanoma, inhibiting MIF improves the response to immune checkpoint blockade by potentiating CD8+ T-cell infiltration and by reorienting MΦ polarization to a proinflammatory M1-like phenotype [45]. This evidence concerns the gene MIF and melanoma.